Pages that link to "Q37135628"
Jump to navigation
Jump to search
The following pages link to EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma (Q37135628):
Displaying 50 items.
- An atlas of combinatorial transcriptional regulation in mouse and man (Q24630300) (← links)
- Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression (Q26829949) (← links)
- Children's Oncology Group's 2013 blueprint for research: bone tumors (Q27027664) (← links)
- Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma (Q28284358) (← links)
- Target gene analysis by microarrays and chromatin immunoprecipitation identifies HEY proteins as highly redundant bHLH repressors (Q28505707) (← links)
- Vorinostat Enhances Cytotoxicity of SN-38 and Temozolomide in Ewing Sarcoma Cells and Activates STAT3/AKT/MAPK Pathways (Q28550980) (← links)
- The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma (Q30313322) (← links)
- Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. (Q33861072) (← links)
- Dual targeting of EWS-FLI1 activity and the associated DNA damage response with trabectedin and SN38 synergistically inhibits Ewing sarcoma cell growth (Q33904684) (← links)
- Notch signaling in pediatric soft tissue sarcomas (Q34480012) (← links)
- Lysyl oxidase is downregulated by the EWS/FLI1 oncoprotein and its propeptide domain displays tumor supressor activities in Ewing sarcoma cells (Q34764399) (← links)
- Notch3 overexpression promotes anoikis resistance in epithelial ovarian cancer via upregulation of COL4A2. (Q35033660) (← links)
- 3D tissue-engineered model of Ewing's sarcoma (Q35428655) (← links)
- A zebrafish transgenic model of Ewing's sarcoma reveals conserved mediators of EWS-FLI1 tumorigenesis (Q35665048) (← links)
- Advances in sarcoma genomics and new therapeutic targets (Q35993346) (← links)
- The first European interdisciplinary ewing sarcoma research summit (Q35993560) (← links)
- Targeted therapy in Ewing sarcoma (Q36011879) (← links)
- HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions (Q36054564) (← links)
- The transcription factor CREBZF is a novel positive regulator of p53. (Q36392179) (← links)
- YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model (Q36545848) (← links)
- Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets (Q36562726) (← links)
- A molecular function map of Ewing's sarcoma (Q37165799) (← links)
- Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis (Q37236770) (← links)
- Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma. (Q37323049) (← links)
- The cytotoxicity of gamma-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by gamma-secretase inhibition. (Q37360220) (← links)
- HEY1 functions are regulated by its phosphorylation at Ser-68. (Q37626853) (← links)
- Notch signaling in solid tumors. (Q37785204) (← links)
- Therapeutic pipeline for soft-tissue sarcoma (Q37931268) (← links)
- Modeling sarcomagenesis using multipotent mesenchymal stem cells (Q37935534) (← links)
- Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis (Q37962606) (← links)
- Prospects and challenges for the development of new therapies for Ewing sarcoma (Q38053823) (← links)
- The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins (Q38192005) (← links)
- The ets transcription factor Fli-1 in development, cancer and disease (Q38218534) (← links)
- Hsa-mir-145 is the top EWS-FLI1-repressed microRNA involved in a positive feedback loop in Ewing's sarcoma (Q38338166) (← links)
- CADASIL mutant NOTCH3(R90C) decreases the viability of HS683 oligodendrocytes via apoptosis (Q38672393) (← links)
- EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma (Q38696838) (← links)
- Chronic stress induces CD99, suppresses autophagy, and affects spontaneous adipogenesis in human bone marrow stromal cells (Q38707037) (← links)
- SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration. (Q38781419) (← links)
- Targeted polytherapy in small cell sarcoma and its association with doxorubicin (Q38977714) (← links)
- Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma (Q39113281) (← links)
- Potential molecular targets for Ewing's sarcoma therapy (Q39650171) (← links)
- miR-125b develops chemoresistance in Ewing sarcoma/primitive neuroectodermal tumor (Q41051759) (← links)
- Targeting the p53 Pathway in Ewing Sarcoma. (Q41303735) (← links)
- Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family. (Q41304204) (← links)
- CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling (Q42392077) (← links)
- Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma (Q50790389) (← links)
- Ewing sarcoma (Q56609038) (← links)
- induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer (Q58790289) (← links)
- MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1 (Q58792269) (← links)
- Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line (Q64069784) (← links)